Key points Main story The State Council of China has introduced fresh guidelines aimed at reforming the country’s drug pricing system, in a move designed to ensure affordability while encouraging innovation within the pharmaceutical sector. The directive, issued by the General Office of the State Council, underscores the need to strengthen a market-oriented mechanism for … Continue reading China unveils new drug pricing reforms to balance affordability and innovation